Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland

BACKGROUND: Hepatitis C virus (HCV) infection is associated with significant morbidity and mortality. Iceland, an island with a population of 330,000 has a HCV seroprevalence of 0.3% and an estimated total of 800–1000 patients. There is good access to health care among people who inject drugs (PWID)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottfredsson, Magnus, Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Bergmann, Ottar M, Bjornsson, Einar S, Johannsson, Birgir, Sigurdardottir, Bryndis, Fridriksdottir, Ragnheidur H, Löve, Arthur, Löve, Thorvardur J, Sigmundsdottir, Gudrun, Heimisdottir, Maria, Olafsson, Sigurdur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632122/
http://dx.doi.org/10.1093/ofid/ofx162.101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632122/
http://dx.doi.org/10.1093/ofid/ofx162.101

Ejemplares similares